Assignee
AFIMMUNE LTD
IE·7 granted patents·15 pending applications·24 citations·filing 2016–2025
Top patents by PatentIndex Score
22 records- 0195US10231945B2Compositions comprising 15-HEPE and methods of using the sameAFIMMUNE LTD·Filed 2017·Granted Mar 19, 2019·8 cites·10 claims
- 0295US9855238B2Compositions comprising 15-HEPE and methods of using the sameAFIMMUNE LTD·Filed 2016·Granted Jan 2, 2018·8 cites·6 claims
- 0389US10813903B2Compositions comprising 15-HEPE and methods of using the sameAFIMMUNE LTD·Filed 2019·Granted Oct 27, 2020·2 cites·24 claims
- 0485US2025186384A1Compositions comprising 15-ohepa and methods of using the sameAFIMMUNE LTD·Filed 2023·Application pending·0 cites
- 0583US10363235B2Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using sameAFIMMUNE LTD·Filed 2016·Granted Jul 30, 2019·5 cites·19 claims
- 0681US12274685B2Compositions comprising 15-HEPE and methods of using the sameAFIMMUNE LTD·Filed 2022·Granted Apr 15, 2025·0 cites·18 claims
- 0778US2025281442A1Compositions comprising 15-hepe and methods of using the sameAFIMMUNE LTD·Filed 2025·Application pending·0 cites
- 0877US2022347147A1Compositions comprising 15-ohepa and methods of using the sameAFIMMUNE LTD·Filed 2022·Application pending·0 cites
- 0976US10716773B2Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic diseaseAFIMMUNE LTD·Filed 2018·Granted Jul 21, 2020·1 cites·8 claims
- 1074US2021244697A1Compositions comprising 15-ohepa and methods of using the sameAFIMMUNE LTD·Filed 2021·Application pending·0 cites
- 1172US2025017887A1Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseasesAFIMMUNE LTD·Filed 2024·Application pending·0 cites
- 1272US2019224154A1Compositions comprising 15-hepe and methods of using the sameAFIMMUNE LTD·Filed 2019·Application pending·0 cites
- 1371US2021228524A1Compositions comprising 15-ohepa and methods of using the sameAFIMMUNE LTD·Filed 2020·Application pending·0 cites
- 1470US12076304B2Compositions comprising 15-HEPE and methods of treating or preventing hematologic disorders, and/or related diseasesAFIMMUNE LTD·Filed 2022·Granted Sep 3, 2024·0 cites·9 claims
- 1563US2021085628A1Compositions comprising 15-hepe and methods of treating or preventing cancer and neurologic diseaseAFIMMUNE LTD·Filed 2020·Application pending·0 cites
- 1655US2024299328A1Compositions comprising 15-hepe and methods of treating and/or preventing hematologic disorders and related diseasesAFIMMUNE LTD·Filed 2024·Application pending·0 cites
- 1753US2021315851A1Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseasesAFIMMUNE LTD·Filed 2020·Application pending·0 cites
- 1852US2019216761A1Compositions comprising 15-hepe and methods of using the sameAFIMMUNE LTD·Filed 2019·Application pending·0 cites
- 1947US2017232021A1Compositions and methods of using sameAFIMMUNE LTD·Filed 2017·Application pending·0 cites
- 2046US2020360331A1COMPOSITIONS COMPRISING 15-HEPE AND/OR 15-HETrE AND METHODS OF TREATING OR PREVENTING CARDIOMETABOLIC DISEASE, METABOLIC SYNDROME, AND/OR RELATED DISEASESAFIMMUNE LTD·Filed 2019·Application pending·0 cites
- 2145US2021085627A1Methods of treating diseases and disorders using compositions comprising 18-hepe, 12-hepe, or combinations thereofAFIMMUNE LTD·Filed 2019·Application pending·0 cites
- 2244US2018008567A1Compositions comprising 15-hepe and methods of using the sameAFIMMUNE LTD·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →